PetCaseFinder

Peer-reviewed veterinary case report

New organ problems help find sepsis and predict outcome in dogs

By Ciuffoli, Elena et al.Ā·Published in Frontiers in veterinary scienceĀ·2024Ā·Department of Veterinary Medical Sciences, ItalyĀ·View original on PubMed →

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: New-onset organ dysfunction as a screening tool for the identification of sepsis and outcome prediction in dogs with systemic inflammation.

Species:
dog

Plain-English summary

A group of critically ill dogs with signs of systemic inflammation were evaluated for new-onset organ dysfunction (OD) to see if it could help predict sepsis and outcomes. Among 275 dogs, those with fluid-refractory hypotension (low blood pressure that doesn't respond to fluids) were more likely to have sepsis. The study found that dogs with multiple organ dysfunctions had a higher risk of death, particularly if they showed signs like acute kidney injury or severe lethargy. While new-onset OD didn't reliably predict sepsis, it was important for identifying dogs at higher risk of poor outcomes, suggesting that early screening for OD could improve care.

People also search for: dog sepsis symptoms Ā· dog low blood pressure treatment Ā· signs of organ dysfunction in dogs

Abstract

INTRODUCTION: Sepsis in people is defined as a life-threatening organ dysfunction (OD) caused by a dysregulated host response to infection. In veterinary medicine, sepsis is still defined by the presence of systemic inflammation plus the evidence of infection. Based on recent veterinary studies, multiorgan dysfunction syndrome (MODS) has been associated with a worse outcome in sepsis. Thus, the screening for OD is warranted to identify the most critically ill patients. The aim of this study was to investigate the diagnostic value of new-onset OD for the prediction of sepsis and outcome in a population of critically ill dogs with systemic inflammation. MATERIALS AND METHODS: Dogs admitted to the Emergency Room and/or the Intensive Care Unit with systemic inflammation, defined by a serum C-reactive protein concentration&#x2009;>&#x2009;1.6&#x2009;mg/dL, were retrospectively included. Enrolled dogs were categorized according to the presence of sepsis or non-infectious systemic inflammation. The presence of newly diagnosed OD was assessed based on criteria adapted from human literature and previously reported canine criteria. RESULTS: 275 dogs were included: 128 had sepsis and 147 had non-infectious systemic inflammation. The frequency of new-onset OD was not different between these groups. Only the presence of fluid-refractory hypotension was significantly associated with a diagnosis of sepsis (OR 10.51, 3.08-35.94;&#x2009;<&#x2009;0.0001). The frequency of at least two ODs was significantly higher in non-survivors compared to survivors, according to both the human and the veterinary criteria considered for the study (&#x2009;=&#x2009;0.0001 and&#x2009;=&#x2009;0.0004, respectively). Specifically, the presence of acute kidney injury, stupor or coma, prolonged Prothrombin Time and decreased Base Excess were associated with a higher risk of death in the multivariate binary logistic regression. DISCUSSION: In this population of critically ill dogs with systemic inflammation, the detection of newly diagnosed ODs was not able to predict sepsis diagnosis, other than the presence of fluid-refractory hypotension. However, given the strong prognostic significance associated with ODs, our results support the early screening for ODs in any severe inflammatory critical care condition to identify high-risk patients and optimize their management.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/38638640/